| Bionentus is a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body's natural healing process. Co. provides a portfolio of active healing products to meet the needs of orthopedist, musculoskeletal and sports medicine physician, podiatrist, neurosurgeon and orthopedic spine surgeon customers and their patients. Co.'s portfolio of products is grouped into three verticals based on clinical use: OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. We show 4 historical shares outstanding datapoints in our BVS shares outstanding history coverage, used to compute BVS market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BVS market cap history over the course of time is important for investors
interested in comparing BVS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BVS versus a peer is one thing; comparing
BVS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BVS can fluctuate over the course of history.
With this page we aim to empower investors researching BVS by allowing them to research the BVS market cap history.